Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P V Luoma

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Pharmacology & Toxicology|August 1, 1997
Gene activation, apolipoprotein A-I/high density lipoprotein, atherosclerosis prevention and longevityP V Luoma
Current Molecular Medicine|May 17, 2011
Gene-activation mechanisms in the regression of atherosclerosis, elimination of diabetes type 2, and prevention of dementiaP V Luoma
Pharmacology & Toxicology|May 1, 1988
Microsomal enzyme induction, lipoproteins and atherosclerosisP V Luoma
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1978
Lysosomal enzymes in hepatic injury induced by bromobenzeneP V Luoma, P S Guzelian
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1981
Saliva and plasma clearance of antipyrine as reflectors of liver functionP V Luoma, E A Sotaniemi
Research Communications in Chemical Pathology and Pharmacology|October 1, 1988
The effects of phenobarbital on serum high density lipoprotein subfractions and apolipoproteinsP V Luoma, J Marniemi, E A Sotaniemi
Journal of Cardiovascular Pharmacology|November 1, 1982
Relationship between plasma high-density lipoprotein cholesterol and anticonvulsant levels in epilepticsP V Luoma, V V Myllylä, E Hokkanen
Scandinavian Journal of Gastroenterology|January 1, 1980
Low high-density lipoprotein and reduced antipyrine metabolism in members of a family with polycystic liver diseaseP V Luoma, E A Sotaniemi, C Ehnholm
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|March 1, 1980
Changes in thyroid function tests during phenobarbital treatment in late pregnancyP V Luoma, J E Heikkinen, P R Ylöstalo
Therapeutic Drug Monitoring|January 1, 1982
Phenobarbital pharmacokinetics and salivary and serum concentrations in pregnancyP V Luoma, J E Heikkinen, P R Ylöstalo
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Pharmacology & Toxicology|August 1, 1997
Gene activation, apolipoprotein A-I/high density lipoprotein, atherosclerosis prevention and longevityP V Luoma
Current Molecular Medicine|May 17, 2011
Gene-activation mechanisms in the regression of atherosclerosis, elimination of diabetes type 2, and prevention of dementiaP V Luoma
Pharmacology & Toxicology|May 1, 1988
Microsomal enzyme induction, lipoproteins and atherosclerosisP V Luoma
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1978
Lysosomal enzymes in hepatic injury induced by bromobenzeneP V Luoma, P S Guzelian
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1981
Saliva and plasma clearance of antipyrine as reflectors of liver functionP V Luoma, E A Sotaniemi
Research Communications in Chemical Pathology and Pharmacology|October 1, 1988
The effects of phenobarbital on serum high density lipoprotein subfractions and apolipoproteinsP V Luoma, J Marniemi, E A Sotaniemi
Journal of Cardiovascular Pharmacology|November 1, 1982
Relationship between plasma high-density lipoprotein cholesterol and anticonvulsant levels in epilepticsP V Luoma, V V Myllylä, E Hokkanen
Scandinavian Journal of Gastroenterology|January 1, 1980
Low high-density lipoprotein and reduced antipyrine metabolism in members of a family with polycystic liver diseaseP V Luoma, E A Sotaniemi, C Ehnholm
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|March 1, 1980
Changes in thyroid function tests during phenobarbital treatment in late pregnancyP V Luoma, J E Heikkinen, P R Ylöstalo
Therapeutic Drug Monitoring|January 1, 1982
Phenobarbital pharmacokinetics and salivary and serum concentrations in pregnancyP V Luoma, J E Heikkinen, P R Ylöstalo
Pageof 5